Most-read rankings are recalculated at the beginning of the month and are based on full-text and pdf views.

11.	Aron A. Barsky, Rohit R. Arora
		Clopidogrel Resistance: Myth or Reality?
		J Cardiovasc Pharmacol Ther Mar 01, 2006; 11: 47-53. (In "Article")   [Abstract]     [PDF]
12.	Maria Rosaria Cesarone, Gianni Belcaro, Luciano Pellegrini, Andrea Ledda, Giulia Vinciguerra, Andrea Ricci, Giuseppe Gizzi, Edmondo Ippolito, Filiberto Fano, Mark Dugall, Giovanni Acerbi, Marisa Cacchio, Andrea Di Renzo, Morio Hosoi, Stefano Stuard, Marcello Corsi
		Circulating Endothelial Cells in Venous Blood as a Marker of Endothelial Damage in Chronic Venous Insufficiency: Improvement with Venoruton
		J Cardiovasc Pharmacol Ther Mar 01, 2006; 11: 93-99. (In "Article")   [Abstract]     [PDF]
13.	Sharon L. Hale, Robert A. Kloner
		The Antianginal Agent, Ranolazine, Reduces Myocardial Infarct Size but Does Not Alter Anatomic No-Reflow or Regional Myocardial Blood Flow in Ischemia/Reperfusion in the Rabbit
		J Cardiovasc Pharmacol Ther Sep 01, 2008; 13: 226-232. (In "Article")   [Abstract]     [PDF]
14.	John J. Warner, Rick A. Weideman, Kevin C. Kelly, Emmanouil S. Brilakis, Subhash Banerjee, Francesca Cunningham, William V. Harford, Salahuddin Kazi, Bertis B. Little, Byron Cryer
		The Risk of Acute Myocardial Infarction With Etodolac is Not Increased Compared to Naproxen: A Historical Cohort Analysis of a Generic COX-2 Selective Inhibitor
		J Cardiovasc Pharmacol Ther Sep 11, 2008; doi: 10.1177/1074248408323136. (In "Article")   [Abstract]
15.	Rohit R. Arora, Ankur G. Shah
		Enhanced External Counterpulsation: A New Modality in the Treatment of Angina and Heart Failure
		J Cardiovasc Pharmacol Ther Dec 01, 2006; 11: 271-273. (In "Article")   [PDF]
[Previous 5 Articles]    [Next 5 Articles]

= from the current issue

Last Updated: 10/05/2008 07:27:29